glp-1 compound vs non compound Tirzepatide Medications: Key Differences Non-Traditional Channels: The Compounded GLP-1
Description
GIP GLP-1
Symptoms include trembling, sweating, confusion, rapid heartbeat, and dizziness
The use of Mounjaro has demonstrated an A1C reduction ranging from 2% to 2.3%, while Ozempic has shown an A1C reduction ranging from 1.4% to 2.1%
In clinical trials, donanemab, which removes amyloid plaques via microglial-mediated clearance, was also found to improve cognition and functional measures in participants with early AD after 76 weeks as compared to placebo (Mintun et al., 2021)
